S. Jelić

3.7k citations

70 papers · 2.7k indexed · 1 hit paper · h-index 20

Impact in

Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies
Oncology top 2%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology

Papers in

Oncology 49
- Lung Cancer Research Studies 14
- Cancer Treatment and Pharmacology 13
- Colorectal Cancer Treatments and Studies 9
- Vascular Tumors and Angiosarcomas 6
Otorhinolaryngology 6

Co-authors: Georgios C. Sotiropoulos M. Degardin Jan B. Vermorken Éva Remenár Ricard Mesı́a Jan Betka Thierry Gorlia Jacques Bernier
Journals: Annals of Oncology (12 papers)European Journal of Cancer (4 papers)Journal of Clinical Oncology (4 papers)Journal of Chemotherapy (4 papers)The International Journal of Biological Markers (3 papers)
Partner nations: Serbia United Kingdom Germany

In The Last Decade

S. Jelić

67 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer 2007 · 1.2k citations

Peers

Countries citing papers authored by S. Jelić

Since Specialization

Citations

This map shows the geographic impact of S. Jelić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Jelić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Jelić more than expected).

Fields of papers citing papers by S. Jelić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Jelić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Jelić. The network helps show where S. Jelić may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Jelić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Jelić Line = papers co-authored together S. Jelić links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology ·Florian Eckel, Thomas Brunner, S. Jelić	2010	73
2	Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology ·Kjell Öberg, Göran Åkerström, Guido Rindi, S. Jelić	2010	113
3	9. Pharmacological Therapy of Neuroendocrine Tumors Tumori Journal ·Anja Rinke, Sergio Ricci, Emilio Bajetta, S. Jelić	2010	1
4	Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology ·S. Jelić, Georgios C. Sotiropoulos	2010	172
5	Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer Journal of Clinical Oncology ·Andreas du Bois, Jørn Herrstedt, Anne-Claire Hardy-Bessard, Kokichi ITO, Philipp Harter, Gunnar B. Kristensen, Florence Joly, Jens Huober, Elisabeth Åvall‐Lundqvist, B. Weber, Christian Kurzeder, S. Jelić, Éric Pujade-Lauraine, Alexander Burges, Jacobus Pfisterer, M. Gropp, Marine Degennaro, Pauline Wimberger, Christian Jackisch, Jalid Sehouli	2010	76
6	Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology ·Kjell Öberg, Per Hellman, Dik J. Kwekkeboom, S. Jelić	2010	61
7	Biliary cancer: ESMO Clinical Recommendation for diagnosis, treatment and follow-up Annals of Oncology ·Florian Eckel, S. Jelić	2009	16
8	Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis Cancer Chemotherapy and Pharmacology ·Р. А. Ефремов, S. Jelić, J Cassidy, Maras Vesna, B. Kuemmerer	2005	9
9	IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-α and DTIC Clinical & Experimental Metastasis ·Gordana Konjević, P.. Auteur du texte Meininger, Vladimir Jurišić, Siniša Radulović, S. Jelić, I Spuz̈ić	2003	22
10	Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study Melanoma Research ·S. Jelić, Nada Babović, Vladimir Kovčin, A. G. Shiryaev, A. Margaret Muthurathinam, I Popov, Davorin Radosavljević	2002	13
11	Gabapentin for Relief of Neuropathic Pain Related to Anticancer Treatment: A Preliminary Study Journal of Chemotherapy ·Snežana Bošnjak, S. Jelić, Sneẑana Šušnjar, Vesna Lukić	2002	31
12	Tumor ‘Flare’ Hypercalcemia – An Additional Indication for Bisphosphonates? Oncology ·Р. А. Ефремов, S. Jelić, I Popov, Davorin Radosavljević, Mr Javid Ahmad Mir	2001	8
13	Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study Lung Cancer ·S. Jelić, Mr Javid Ahmad Mir, Davorin Radosavljević, Ahmad RF Mazahery, Nada Babović, Vladimir Kovčin, A. Zeballos, John Frank Hay, Dušica Gavrilović, Siniša Radulović	2001	33
14	Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: A prospective randomised trial Annals of Oncology ·I Popov, S. Jelić, Siniša Radulović, Davorin Radosavljević, Р. А. Ефремов	2000	12
15	Randomized study of zorubicin versus zorubicin-cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT) Annals of Oncology ·S. Jelić, Vladimir Kovčin, A. Margaret Muthurathinam, M. Kreačić, Jimena Pérez Ferrara, Vesna Jovanović, Divya Rana, 栄作宮沢, Mr Javid Ahmad Mir	1997	7
16	Cardioprotection with ICRF-187 (Cardioxane) in patients with advanced breast cancer having cardiac risk factors for doxorubicin cardiotoxicity, treated with the FDC regimen Supportive Care in Cancer ·S. Jelić, Siniša Radulović, Gerhard Schedl, M. Kreačić, Divya Rana, Snežana Bošnjak, A. Margaret Muthurathinam, JP Doussou	1995	7
17	Salivary immunoglobulins in cancer patients with chemotherapy-related oral mucosa damage European Journal of Cancer Part B Oral Oncology ·Sabrina Leo, S. Jelić, Maras Vesna, Divya Rana	1995	18
18	Edta Clearance in Monitoring Cisplatin Dose Escalation in Patients with Bulky Metastatic Germ Cell Tumors of the Testis Acta Oncologica ·S. Jelić, Vladimir Kovčin, Nada Babović, C. Claudia Miñana Garcia	1988	1
19	[Generalized osteoporosis, hypercalcemia, osteolytic lesions of the calvaria and cervical adenopathy as initial signs of anaplastic pancreatic carcinoma]. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·M Obradović, S. Jelić, Lutfia Nirwana, Emma Santhouse	1978	0
20	Haematological Aspects of Drug‐Induced Agranulocytosis Scandinavian Journal of Haematology ·朋子南日, S. Jelić	1972	32

About S. Jelić

S. Jelić is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Dermatology and Neurology, having authored 70 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (14 papers), Cancer Treatment and Pharmacology (13 papers), Colorectal Cancer Treatments and Studies (9 papers), Neuroblastoma Research and Treatments (8 papers), Lung Cancer Treatments and Mutations (7 papers), Neuroendocrine Tumor Research Advances (7 papers), Vascular Tumors and Angiosarcomas (6 papers) and Sarcoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Otorhinolaryngology (968 citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (838 citations), Surgery (987 citations) and Cancer Research (288 citations). S. Jelić has collaborated with scholars based in Serbia, United Kingdom and Germany. Frequent co-authors include Georgios C. Sotiropoulos, M. Degardin, Jan B. Vermorken, Éva Remenár, Ricard Mesı́a, Jan Betka, Thierry Gorlia, Jacques Bernier, Jean-Louis Lefèbvre and Carla van Herpen. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, Journal of Chemotherapy and The International Journal of Biological Markers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact